TrkB/mGluR5 cross-talk underlies a synaptic metaplasticity mechanism of ketamine
Science Advances · 2026-05-01 · 12 (18)
DOI: 10.1126/sciadv.aec1444 ↗At a glance
Journal article in Science Advances, published on 2026-05-01. Written by Anisul Arefin and 6 co-authors. Institution: Department of Biochemistry and Biophysics, Weill Cornell Medicine, New York, NY 10065, USA. Major MEDLINE topics: Ketamine, Receptor, Metabotropic Glutamate 5, Receptor, trkB, Neuronal Plasticity. Cited 4 times so far (Crossref); 119 references. The full text is freely available in PubMed Central. Funded by: NIMH NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (original language)
A complex ensemble of neuromodulatory receptors orchestrates the many forms of synaptic plasticity that drive behavioral state changes, but an understanding of how such receptors functionally interact is limited. Here, we find that the antidepressant action of ketamine is dependent on both the receptor tyrosine kinase, tropomyosin-related kinase B (TrkB), and the G protein–coupled receptor, metabotropic glutamate receptor 5 (mGluR5). mGluR5 amplifies brain-derived neurotrophic factor (BDNF)–driven signaling of TrkB, enabling synaptic potentiation via “signaling cross-talk,” while BDNF activation of TrkB drives mGluR5 endocytosis via “trafficking cross-talk,” impairing synaptic depression. These modes of cross-talk are enhanced by ketamine, which increases surface and postsynaptic levels of TrkB. Last, we find that an mGluR5 positive allosteric modulator can enhance both modes of cross-talk and boost the effects of ketamine. Together, these data unravel the intimate relationship between different classes of neuromodulatory receptors, revealing that receptor-receptor interplay can drive therapeutic action.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Biochemistry and Biophysics, Weill Cornell Medicine, New York, NY 10065, USA.
- Department of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
ORCID profiles: Anisul Arefin, Jihye Kim, Manas Pratim Chakraborty, Silvia Martinelli, Francis S Lee, Joshua Levitz
Funding
- NIMH NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- Burroughs Wellcome Fund
- Pritzker Neuropsychiatric Disorders Research Consortium
- The Monique Weil-Caulier Award
Cite
APA
Arefin, A., Kim, J., Chakraborty, M. P., Martinelli, S., Bai, B., Lee, F. S., & Levitz, J. (2026). TrkB/mGluR5 cross-talk underlies a synaptic metaplasticity mechanism of ketamine. Science Advances, 12(18). https://doi.org/10.1126/sciadv.aec1444
Vancouver
Arefin A, Kim J, Chakraborty MP, Martinelli S, Bai B, Lee FS, et al. TrkB/mGluR5 cross-talk underlies a synaptic metaplasticity mechanism of ketamine. Science Advances. 2026;12(18). doi:10.1126/sciadv.aec1444
BibTeX
@article{Arefin2026,
author = {Arefin, Anisul and Kim, Jihye and Chakraborty, Manas Pratim and Martinelli, Silvia and Bai, Betty and Lee, Francis S and Levitz, Joshua},
title = {TrkB/mGluR5 cross-talk underlies a synaptic metaplasticity mechanism of ketamine},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {18},
doi = {10.1126/sciadv.aec1444}
}
EUVIMED